Tags

Type your tag names separated by a space and hit enter

Effect of Baduanjin exercise for hypertension: a systematic review and meta-analysis of randomized controlled trials.
Maturitas. 2015 Apr; 80(4):370-8.M

Abstract

This study aims to evaluate the efficacy of Baduanjin exercise for hypertension. Cochrane Library, PubMed, EMBASE, CNKI, VIP, CBM and Wanfang databases were searched. Eight randomized controlled trials (RCTs) were identified. Baduanjin significantly lowered systolic blood pressure (SBP) (WMD=-13.00 mmHg; 95% CI: -21.24 to -4.77; P=0.002), diastolic blood pressure (DBP) (WMD=-6.13 mmHg; 95% CI: -11.20 to -1.07; P=0.02), body mass index, blood glucose, triglyceride, and low-density lipoprotein-cholesterol, and improved high-density lipoprotein-cholesterol and quality of life compared to no intervention. No significant difference between Baduanjin and antihypertensive drugs on SBP (WMD=1.05 mmHg; 95% CI: -2.07 to 4.17; P=0.51) or DBP (WMD=1.90 mmHg; 95% CI: -1.22 to 5.02; P=0.23) was identified. Baduanjin plus antihypertensive drugs significantly reduced SBP (WMD=-7.49 mmHg; 95% CI: -11.39 to -3.59; P=0.0002), DBP (WMD=-3.55 mmHg; 95% CI: -5.25 to -1.85; P<0.0001), blood glucose, and total cholesterol compared to antihypertensive drugs. Baduanjin is an effective therapy for hypertension. However, further rigorously designed RCTs are still warranted.

Authors+Show Affiliations

Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Electronic address: xiongxingjiangtcm@163.com.Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.Department of Biological Science and Technology, School of Life Sciences, Tsinghua University, Beijing, China.Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada.Bio-organic and Natural Products Laboratory, McLean Hospital, Harvard Medical School, Belmont, MA, USA.

Pub Type(s)

Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Review
Systematic Review

Language

eng

PubMed ID

25636242

Citation

Xiong, Xingjiang, et al. "Effect of Baduanjin Exercise for Hypertension: a Systematic Review and Meta-analysis of Randomized Controlled Trials." Maturitas, vol. 80, no. 4, 2015, pp. 370-8.
Xiong X, Wang P, Li S, et al. Effect of Baduanjin exercise for hypertension: a systematic review and meta-analysis of randomized controlled trials. Maturitas. 2015;80(4):370-8.
Xiong, X., Wang, P., Li, S., Zhang, Y., & Li, X. (2015). Effect of Baduanjin exercise for hypertension: a systematic review and meta-analysis of randomized controlled trials. Maturitas, 80(4), 370-8. https://doi.org/10.1016/j.maturitas.2015.01.002
Xiong X, et al. Effect of Baduanjin Exercise for Hypertension: a Systematic Review and Meta-analysis of Randomized Controlled Trials. Maturitas. 2015;80(4):370-8. PubMed PMID: 25636242.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Effect of Baduanjin exercise for hypertension: a systematic review and meta-analysis of randomized controlled trials. AU - Xiong,Xingjiang, AU - Wang,Pengqian, AU - Li,Shengjie, AU - Zhang,Yuqing, AU - Li,Xiaoke, Y1 - 2015/01/09/ PY - 2014/12/21/received PY - 2015/01/04/accepted PY - 2015/2/1/entrez PY - 2015/2/1/pubmed PY - 2016/3/31/medline KW - Baduanjin KW - Hypertension KW - Randomized controlled trial KW - Systematic review SP - 370 EP - 8 JF - Maturitas JO - Maturitas VL - 80 IS - 4 N2 - This study aims to evaluate the efficacy of Baduanjin exercise for hypertension. Cochrane Library, PubMed, EMBASE, CNKI, VIP, CBM and Wanfang databases were searched. Eight randomized controlled trials (RCTs) were identified. Baduanjin significantly lowered systolic blood pressure (SBP) (WMD=-13.00 mmHg; 95% CI: -21.24 to -4.77; P=0.002), diastolic blood pressure (DBP) (WMD=-6.13 mmHg; 95% CI: -11.20 to -1.07; P=0.02), body mass index, blood glucose, triglyceride, and low-density lipoprotein-cholesterol, and improved high-density lipoprotein-cholesterol and quality of life compared to no intervention. No significant difference between Baduanjin and antihypertensive drugs on SBP (WMD=1.05 mmHg; 95% CI: -2.07 to 4.17; P=0.51) or DBP (WMD=1.90 mmHg; 95% CI: -1.22 to 5.02; P=0.23) was identified. Baduanjin plus antihypertensive drugs significantly reduced SBP (WMD=-7.49 mmHg; 95% CI: -11.39 to -3.59; P=0.0002), DBP (WMD=-3.55 mmHg; 95% CI: -5.25 to -1.85; P<0.0001), blood glucose, and total cholesterol compared to antihypertensive drugs. Baduanjin is an effective therapy for hypertension. However, further rigorously designed RCTs are still warranted. SN - 1873-4111 UR - https://www.unboundmedicine.com/medline/citation/25636242/Effect_of_Baduanjin_exercise_for_hypertension:_a_systematic_review_and_meta_analysis_of_randomized_controlled_trials_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0378-5122(15)00004-3 DB - PRIME DP - Unbound Medicine ER -